[{"data":1,"prerenderedAt":175},["ShallowReactive",2],{"newsletter-\u002Fnewsletter\u002Fnonoppain":3},{"id":4,"title":5,"author":6,"body":7,"date":166,"description":167,"extension":168,"meta":169,"navigation":170,"path":171,"seo":172,"stem":173,"__hash__":174},"newsletter\u002Fnewsletter\u002Fnonoppain.md","The Rise of Non-Opioid Pain Relief","Shereen Ali",{"type":8,"value":9,"toc":154},"minimark",[10,15,34,38,42,45,55,59,62,65,69,72,75,84,92,96,99,102,109,115,125,128,131,134,137,140,143,151],[11,12,14],"h2",{"id":13},"in-brief","In Brief",[16,17,18,22,25,28,31],"ul",{},[19,20,21],"li",{},"Opioids’ high potential for addiction and abuse has led to strict legal institutional controls",[19,23,24],{},"Non-opioid painkillers are designed to relieve severe pain without the risks of addiction",[19,26,27],{},"Categorizing pain ensures the precise selection of targeted first-line non-opioids",[19,29,30],{},"Newer medications selectively inhibit Nav1.8 sodium channels on peripheral sensory neurons",[19,32,33],{},"Non-opioids target the peripheral nervous system (PNS) to block or reduce pain signals at their origin before they reach the brain",[11,35,37],{"id":36},"introduction","Introduction",[39,40,41],"p",{},"The pain is sharp and constant, your body aching from every incision. After major surgery, waking up in a hospital bed while still feeling the effects of anesthesia leaves you wanting only one thing: relief. Yet when you arrive at the pharmacy to fill your prescription, you are told that the opioid painkiller your doctor ordered cannot be fully dispensed—regulatory restrictions and limited inventory stand between you and the medication you need. This scenario is not uncommon. Opioids such as morphine and oxycodone remain among the most effective treatments for post-surgical pain, but their high potential for addiction and abuse has led to strict legal institutional controls that often leave patients without adequate access, even in moments of legitimate medical need.",[39,43,44],{},"There is an emerging solution to this dilemma: non-opioid surgical painkillers, a class of treatments designed to relieve severe pain without the risks of addiction. If successfully developed and implemented, these alternatives could transform patient care by eliminating the risk of abuse, reducing dangerous side effects, and preventing the onset of chronic pain, all of which enables faster, more complete recovery. Understanding the clinical potential of these non-opioid options is essential not only for improving the individual patient outcomes, but for reshaping how the healthcare industry approaches pain management as a whole.",[39,46,47],{},[48,49],"img",{"alt":50,"className":51,"src":53,"style":54},"Diagram explaining what pain is",[52],"rounded-lg","\u002Fnewsletter\u002Fnonoppain\u002Fwhat.png","display: block; margin-inline: auto;",[11,56,58],{"id":57},"current-state","Current State",[39,60,61],{},"Diagnostic measures for non-opioid pain management rely on clinical evaluation, validated scoring tools, and mechanism-specific testing. This process categorizes pain as nociceptive, inflammatory, or neuropathic. Identifying these mechanisms ensures the precise selection of targeted first-line non-opioids, such as NSAIDs, acetaminophen, or specific adjuvant medications.",[39,63,64],{},"Nociceptive pain is assessed through localized tenderness and functional limitation, fit for acetaminophen or short-term anti-inflammatory therapy. Ibuprofen, naproxen, celecoxib, and meloxicam reduce inflammation and pain. They are first-line agents for musculoskeletal pain, postoperative pain, and inflammatory conditions (American Academy). Furthermore, neuropathic pain is diagnosed via sensory testing and clinical scoring tools (e.g., LANSS or DN4) for conditions like diabetic neuropathy or postherpetic neuralgia, targeting antiepileptic drugs (Zero). Lastly, inflammatory pain is diagnosed via physical examination, imaging (X-ray\u002FMRI), or inflammatory marks confirming conditions like osteoarthritis or acute injury, matching target patients to oral or topical NSAIDs. This identification of patient categories and matching measures ensures patients receive highly effective, tailored pain management by directly aligning specific pain mechanisms with the safest and most appropriate non-opioid medications.",[11,66,68],{"id":67},"sodium-channels-pns","Sodium Channels & PNS",[39,70,71],{},"Sodium channels are a diverse family of isoform proteins with unique expression patterns and functions. They are located in the cell membrane of excitable and absorptive cells throughout the body, specifically concentrated in neurons, muscle cells, and epithelial tissues. The targeting of a single isoform can alter pain sensations. Thus, these channels play a role in the maintenance of inflammatory pain states (Levinson). Consequently, selectively blocking these specific channels offers a promising pathway for developing effective non-opioid painkillers without the risk of addiction.",[39,73,74],{},"Non-opioid painkillers like NSAIDs directly target inflammatory pain states. They block cyclooxygenase (COX) enzymes, stopping the body from making prostaglandins—the chemical signals that cause tissue swelling, redness, and sensitize pain nerves. This makes non-opioids the primary, most effective first-line treatment for mild-to-moderate inflammatory conditions (Milani).",[39,76,77,78,83],{},"Additionally, sodium channel subtypes are crucial for understanding the mechanism of non-opioid painkillers. For example, Nav1.8 is a voltage-gated sodium channel protein encoded by the SCN10A gene that plays a critical role in transmitting pain signals. It is found mainly in the sensory neurons of the peripheral nervous system (PNS), making it a major target for developing non-addictive, non-opioid pain medications.\n",[48,79],{"alt":80,"className":81,"src":82,"style":54},"Diagram showing the CNS and PNS",[52],"\u002Fnewsletter\u002Fnonoppain\u002Fcns.png","\nEssentially, these voltage-gated sodium channels in the peripheral nervous system act as electrical switches that generate and transmit pain signals from injured tissue to the brain. Because these channels exist exclusively outside the brain and spinal cord, the drugs work entirely in the peripheral nervous system (Wiegmann).",[39,85,86,87],{},"Modern non-opioid surgical painkillers, such as the selective Nav1.8 inhibitor suzetrigine (Journavx), block these specific peripheral channels to stop pain messages before they reach the central nervous system, avoiding addiction risks. The drug binds specifically to the voltage-sensing domain 2 of the NaV1.8 channel, locking it in a closed state to prevent the influx of sodium ions. This action blocks the generation of action potentials in pain-sensing neurons, stopping the transmission of pain signals at the source without causing central nervous system side effects like sedation.\n",[48,88],{"alt":89,"className":90,"src":91,"style":54},"Diagram showing the Nav 1.8 channel that non-opioid medications operate on",[52],"\u002Fnewsletter\u002Fnonoppain\u002Fdiag.png",[11,93,95],{"id":94},"conclusion","Conclusion",[39,97,98],{},"Ultimately, non-opioid pain killer research has accelerated rapidly, focusing on highly targeted alternatives like peripheral sodium channel blockers and advanced multimodal therapies. Driven by the urgent medical need to bypass regulatory hurdles and dependency risks, the global market for these non-addictive treatments is predicted to grow exponentially over the coming decade. Fundamentally, these innovations promise a future where surgical recovery is defined by effective, unhindered relief rather than the complications of supply shortages and addiction.",[100,101],"hr",{},[103,104,108],"h3",{"className":105,"id":107},[106],"text-center","works-cited","Works Cited",[100,110],{"className":111},[112,113,114],"border-cyan-700","mx-auto","max-w-[80cqw]",[39,116,117,118,124],{},"American Academy of Procedural Medicine. “Pain Management without Opioids: 12 Evidence-Based Approaches.” AAOPM - American Academy of Procedural Medicine, American Academy of Procedural Medicine, 21 Mar. 2026, ",[119,120,121],"a",{"href":121,"rel":122},"https:\u002F\u002Faaopm.com\u002Fblog\u002Fpain-management-without-opioids\u002F#non-opioid-medications",[123],"nofollow",". Accessed 17 July 2026.",[39,126,127],{},"Cleveland Clinic. “Peripheral Nervous System (PNS): What It Is & Function.” Cleveland Clinic, 25 May 2022.",[39,129,130],{},"Hernandez, Carlos M., and John R. Richards. “Physiology, Sodium Channels.” StatPearls Publishing, 2021.",[39,132,133],{},"Levinson, Simon R et al. “The role of sodium channels in chronic pain.” Muscle & nerve vol. 46,2 (2012): 155-65. doi:10.1002\u002Fmus.23314",[39,135,136],{},"Milani, Daniel A. Queremel , and Donald D. Davis. “Pain Management Medications.” StatPearls Publishing, 2023.",[39,138,139],{},"Wiegmann, Aaron L et al. “Suzetrigine: What Should Plastic Surgeons Know?.” Plastic and reconstructive surgery. Global open vol. 14,1 e7431. 16 Jan. 2026, doi:10.1097\u002FGOX.0000000000007431",[39,141,142],{},"Woolf, Clifford J. “What is this thing called pain?.” The Journal of clinical investigation vol. 120,11 (2010): 3742-4. doi:10.1172\u002FJCI45178",[39,144,145,146,150],{},"Wu, Zhixing, and Dai Lu. “Advances in the Discovery of Selective NaV1.8 Inhibitors for Pain Management.” European Journal of Medicinal Chemistry, vol. 302, 30 Oct. 2025, p. 118326, ",[119,147,148],{"href":148,"rel":149},"https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0223523425010918",[123],", 10.1016\u002Fj.ejmech.2025.118326. Accessed 1 Aug. 2026.",[39,152,153],{},"Zero To Finals. “Understanding the Causes of Pain and Pain Management.” 10 Oct. 2022.",{"title":155,"searchDepth":156,"depth":156,"links":157},"",2,[158,159,160,161,162],{"id":13,"depth":156,"text":14},{"id":36,"depth":156,"text":37},{"id":57,"depth":156,"text":58},{"id":67,"depth":156,"text":68},{"id":94,"depth":156,"text":95,"children":163},[164],{"id":107,"depth":165,"text":108},3,"2026-08-10","Opioids are highly dangerous and addictive, but are still used for pain relief. Non-opioid painkillers are being designed to overcome the risks of addiction.","md",{"image":91},true,"\u002Fnewsletter\u002Fnonoppain",{"title":5,"description":167},"newsletter\u002Fnonoppain","vDEMN3Xd1_HsHB7M0SdBnefkqByo66NsQw-kvJkW-PQ",1789320737548]